Chronic Treatment Acceptance Questionnaire (ACCEPT)

Developed in 2008

WEBINAR: An Author Webinar on the Chronic Treatment Acceptance Questionnaire - Recorded session available here!

Arnould B, Gauchoux R, Meunier J, Gilet H, Regnault A. Validation of ACCEPT, a new generic measure to assess how patients with chronic diseases balance between the advantages and disadvantages of following the recommended treatment regimen in real-life. ISPOR 16th Annual European Congress, Dublin, Ireland, November 2013

Marant C, Longin J, Gauchoux R, Arnould B, Spizak C, Marrel A, Patrick DL, Van Ganse E. Long-term treatment acceptance: what is it, and how can it be assessed? Patient. 2012;5(4):239-49 (PubMed Abstract)

Chretin S, Viala-Danten M, Van Ganse E, Patrick D, Arnould B, Longin J. The missing piece between treatment experience and intention to persist: testing the internal consistency reliability and predictive validity of acceptability.  ISPOR 13th Annual European Congress, Prague, Czech Republic, November 2010

Marant C, Longin J, Spizak C, Patrick D, Saussier C, Arnould B, Van Ganse E. What does acceptability mean for patients and how should it be measured? Qualitative steps for the development of a new measurement instrument for pharmacies: the “ACCEPT©” questionnaire. ISPOR 11th Annual European Congress, Athens, Greece, November 2008

•     ACCEPT User Agreement

* Excluding VAT
Commercial users: Industry, CRO, any for-profit companies
Funded Academic research: Projects receiving funding from commerce, government, EU or registered charity. Funded academic research– sponsored by industry fits the “commercial users” category.
Not funded academic users, individual medical practice: Projects are not explicitly funded, but funding comes from overall departmental funds or from the University or individual funds

Webpage dedicated to the ACCEPT

Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.

• ACCEPT in French for France (original version)
• ACCEPT in English for the UK

The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.